MSC303 Subcutaneous Injection for the Treatment of Immunologic Glomerular Disease.

Clinical trial NCT07000292 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07000292
Sponsor: Shanghai Changzheng Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Lupus Nephritis (LN)ANCA-Associated Glomerulonephritis

Start date: 2025-06-20
Primary completion: 2026-05-20
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.